Incidence of antimicrobial-resistant ventilator associated pneumonia: An eighteen-month survey

Panminerva Medica

Volumn 47, Issue 4, 2005, Pages 265-267

  Piazza, O ^a   Iasiello, A ^a   Papaianni, C ^a   De Robertis, E ^a   Servillo, G ^a   Rossano, F ^a   Tufano, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Intensive care unit; Mechanical ventilation; Resistance; Ventilator associated pneumonia

Indexed keywords

ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIAL PNEUMONIA; FEMALE; HUMAN; INCIDENCE; MALE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; REVIEW; VENTILATOR;

ADULT; AGED; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; VENTILATORS, MECHANICAL;

EID: 33645290497     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Bellani S, Nesci M, Celotto S, Lampati L, Lucchini A. Ventilator associated pneumonia. Minerva Anestesiol 2003;69:315-9.
2. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garcia-Garmendia JL, Bernabeu-Wittell M et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003;36:1111-8.
3. rd, Cox JC, Bee TK et al. The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures. J Trauma 2004;56:931-4.
4. Schurink CA, Van Nieuwenhoven CA, Jacobs JA, Rozenberg-Arska M, Joore HC, Buskens E et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med 2004;30:217-24.
5. Erden V, Basaranoglu G, Beycan I, Delatioglu H, Hamzaoglu NS. Reproducibility of mini-BAL culture results using 10 ml or 20 ml instilled fluid. Intensive Care Med 2003;29:1856.
6. Zarrilli R, Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 2004;42:946-53.
7. Rang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC et al. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa. Microb Drug Resist 2005;11:68-74.
8. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD et al. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis 2004;39:812-8.
9. Mehta RM, Niederman MS. Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. J Intensive Care Med 2003;18: 175-88.
10. El-Solh AA, Okada M, Pietrantoni C, Aquilina A, Berbary E. Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: impact of inadequate antimicrobial therapy. Intensive Care Med 2004;30:1914-20.
11. Corona A, Raimondi F. Prevention of nosocomial infection in the ICU setting. Minerva Anestesiol 2004;70:329-37.
12. Bonten MJ, Kollef MH, Hall JB. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004;38:1141-9.
13. Berra L, Panigada M, De Marchi L, Greco G, Z -Xi Y, Baccarelli A et al. New approaches for the prevention of airway infection in ventilated patients. Lessons learned from laboratory animal studies at the National Institutes of Health. Minerva Anestesiol 2003;69:342-7.